29-MAY-2026 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2409-ESCLC, Durvalumab +/- Biomarker Directed Tx 1 Y 0 Screening & Cohort Assignment 900 38 38 34 21 5 0 11/06/2025 233 68
            38 38 34 21 5 0      
 
    2 Y 1 Durvalumab   3 3 3 2 1 0 11/06/2025    
        2 Durvalumab + Saruparib   3 3 3 3 1 1      
        5 Durvalumab   1 1 1 1 1 1      
            7 7 7 6 3 2      
 
  S2414-NSCLC, Stg II-IIIB, Durva vs Surveillance 1 Y 1 Durvalumab 306 5 4 2 2 1 0 04/01/2025 271 84
        2 Surveillance   4 4 2 1 0 0      
            9 8 4 3 1 0      
 
Yes A081801-ALCHEMIST4, ALK and EGFR negative, Chemo-IO 1 E Total Registrations   108 16 8 5 3 1 10/20/2020 433 166
            108 16 8 5 3 1      
 
  EA5162-NSCLC,StgIV/IIB,EGFR exon20 insertion,AZD9291 1 E Total Registrations   4 0 0 0 0 0 08/23/2023 90 33
            4 0 0 0 0 0      
 
  EA5182-NSCLC, Met EGFR mut, AZD9291+Beva vs AZD9291 1 E Total Registrations   26 3 1 0 0 0 04/28/2021 230 82
            26 3 1 0 0 0      
 
  EA5221-Lung, Advanced NSCLC, ChemoImmuno/Immuno 1 E Total Registrations   5 2 0 0 0 0 08/07/2024 216 81
            5 2 0 0 0 0      
 
    2 E Total Registrations   4 2 0 0 0 0 08/07/2024    
            4 2 0 0 0 0      
 
  NRGLU008-Lung NSCL, StgII-III, StereoBodyRad/MedChemo 1 E Total Registrations   5 2 0 0 0 0 01/26/2024 335 129
            5 2 0 0 0 0      
 
No S2402-NSCLC, All Stg, Periop Vs Adj Tx 1 E Total Registrations   8 5 4 1 0 0 04/22/2025 142 64
            8 5 4 1 0 0      
 
  A082002-Lung, Adv, Systemic Tx +/- SBRT 1 E Total Registrations   4 0 0 0 0 0 10/12/2022 257 74
            4 0 0 0 0 0